OA
Clinical Immunology & Microbiology Research
Aim & Scope
Aim
Clinical Immunology & Microbiology Research aims to provide an international scientific platform for researchers, clinicians, microbiologists, immunologists, and healthcare professionals to publish high-quality research on immune responses, microorganisms, infectious diseases, and their clinical implications. The journal seeks to promote interdisciplinary research that advances understanding of host–microbe interactions, disease mechanisms, diagnosis, prevention, and therapeutic approaches.
Scope
Clinical Immunology & Microbiology Research is an interdisciplinary journal covering research at the intersection of clinical immunology, medical microbiology, infectious diseases, and immune-mediated disorders. The journal welcomes original research, review articles, case reports, and other scientifically relevant manuscripts.
Areas of interest include:
- Clinical and diagnostic immunology
- Cellular and molecular immunology
- Innate and adaptive immunity
- Immunopathology and inflammation
- Autoimmune and immune-mediated diseases
- Immunodeficiency and immunological disorders
- Medical and clinical microbiology
- Bacteriology and bacterial infections
- Virology and viral infections
- Mycology and fungal infections
- Parasitology and parasitic diseases
- Host–pathogen interactions
- Microbial pathogenesis and virulence
- Antimicrobial resistance and susceptibility
- Microbiological diagnostics
- Serology, antibodies, and immunological biomarkers
- Vaccines and immunization
- Infection-associated immune responses
- Microbiome and human health
- Molecular microbiology and microbial genetics
- Translational and laboratory-based clinical research
- Emerging and re-emerging infectious diseases
- Immunotherapy and immune-based approaches to disease
- Public health microbiology and infection control
The journal particularly encourages studies that connect microbial infections with host immune responses and research with potential clinical or diagnostic applications.